These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7923151

  • 1. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
    Xu L, Sgroi D, Sterner CJ, Beauchamp RL, Pinney DM, Keel S, Ueki K, Rutter JL, Buckler AJ, Louis DN.
    Cancer Res; 1994 Oct 15; 54(20):5262-4. PubMed ID: 7923151
    [Abstract] [Full Text] [Related]

  • 2. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 3. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ, Aldaz CM.
    Cancer Res; 1995 Jul 01; 55(13):2892-5. PubMed ID: 7796417
    [Abstract] [Full Text] [Related]

  • 4. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
    Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K.
    Cancer Res; 1995 Jul 01; 55(13):2756-60. PubMed ID: 7796400
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K, Conrad NK, Williams JP, Johnson BE, Kelley MJ.
    Oncogene; 1995 Nov 02; 11(9):1843-51. PubMed ID: 7478613
    [Abstract] [Full Text] [Related]

  • 6. p27/Kip1 mutation found in breast cancer.
    Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP.
    Cancer Res; 1996 May 15; 56(10):2400-4. PubMed ID: 8625318
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 15; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 8. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep 15; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 9. p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines.
    Hirama T, Miller CW, Wilczynski SP, Koeffler HP.
    Mod Pathol; 1996 Jan 15; 9(1):26-31. PubMed ID: 8821952
    [Abstract] [Full Text] [Related]

  • 10. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK.
    Oncogene; 1995 Mar 16; 10(6):1061-7. PubMed ID: 7700630
    [Abstract] [Full Text] [Related]

  • 11. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 16; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
    Tung WS, Shevlin DW, Bartsch D, Norton JA, Wells SA, Goodfellow PJ.
    Mol Carcinog; 1996 Jan 16; 15(1):5-10. PubMed ID: 8561866
    [Abstract] [Full Text] [Related]

  • 15. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM, Pearson JV, Hayward NK.
    Genes Chromosomes Cancer; 1996 Feb 16; 15(2):77-88. PubMed ID: 8834170
    [Abstract] [Full Text] [Related]

  • 16. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM.
    Genes Chromosomes Cancer; 1997 Jun 16; 19(2):84-9. PubMed ID: 9171998
    [Abstract] [Full Text] [Related]

  • 17. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
    Chen TC, Hsieh LL, Kuo TT, Ng KF, Wu Chou YH, Jeng LB, Chen MF.
    Anticancer Res; 2000 Jun 16; 20(3A):1621-6. PubMed ID: 10928081
    [Abstract] [Full Text] [Related]

  • 18. Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis.
    Luca M, Xie S, Gutman M, Huang S, Bar-Eli M.
    Oncogene; 1995 Oct 05; 11(7):1399-402. PubMed ID: 7478563
    [Abstract] [Full Text] [Related]

  • 19. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 20. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW.
    Genes Chromosomes Cancer; 1996 Sep 01; 17(1):14-20. PubMed ID: 8889502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.